Méndez-Ríos U, Ortiz-Almeyda HF, Jiménez-Olmedo D, Hernández-Zamonsett D

Language: English
References: 7
Page: 171-173
PDF size: 1707.79 Kb.

ABSTRACT

We describe a five-year-old female with Down syndrome and patent ductus arteriosus. During percutaneous closure using an Amplatzer device, embolization to the right pulmonary artery occurred. Successful surgical rescue was achieved via sternotomy, including device extraction, pulmonary artery plasty, and ductal ligation without cardiopulmonary bypass. The postoperative course was uneventful. Immediate surgical management is safe and effective for device migration, a serious complication of transcatheter closure.

REFERENCES

1. Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus ofthe preterm infant. Pediatrics. 2020;146(5):e20201209.

2. El-Said HG, Bratincsak A, Foerster SR, et al. Safety of percutaneouspatent ductus arteriosus closure: an unselected multicenter populationexperience. J Am Heart Assoc. 2013;2(6):e000424.

3. Yildiz K Sr, Kir M, Prencuva P, et al. Transcatheter patent ductusarteriosus closure in children with different devices and long-termresults. Cureus. 2023;15(10):e46504.

4. Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA,Hasanah I. The Amplatzer duct occluder: experience in 209 patients. JAm Coll Cardiol. 2001;37(1):258-261.

5. Choi GJ, Song J, Kim YS, et al. Outcomes of transcatheter closure ofductus arteriosus in infants less than 6 months of age: a single-centerexperience. Korean J Pediatr. 2018;61(12):397-402. doi: 10.3345/kjp.2018.06548.

6. Jaile JC 4th, Siwik E, Bartakian S. Left pulmonary artery occlusionfollowing device closure of patent ductus arteriosus in prematureinfants. J Soc Cardiovasc Angiogr Interv. 2023;3(2):101194.

7. Liao XY, Li JJ, Zeng SY, et al. Successful interventional closureof patent ductus arteriosus in three pediatric cases with congenitalheart disease and severe pulmonary hypertension: a case series andliterature review. Front Cardiovasc Med. 2025;12:1628666.